SCHEMBL29944901

SCHEMBL29944901

Nc1nc2cc(Cl)ccc2s1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.61
IDO1 P14902 1/20 0.61
SMN1; SMN2 Q16637 2/20 0.56
NPSR1 Q6W5P4 1/20 0.56
PIK3CD O00329 1/20 0.54
PIK3CA P42336 1/20 0.54
PIK3CB P42338 1/20 0.54
PIK3CG P48736 1/20 0.54
ALDH1A1 P00352 2/20 0.50
TP53 P04637 1/20 0.50
CYP3A4 P08684 1/20 0.50
TSHR P16473 1/20 0.50
EPHX2 P34913 1/20 0.48
HDAC6 Q9UBN7 1/20 0.47
RAB9A P51151 2/20 0.47
GAA P10253 2/20 0.47
MAPT P10636 1/20 0.47
AXL P30530 1/20 0.47
GFER P55789 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL482340 1.00 LOXL2 (0.61) LOXL2IDO1SMN1; SMN2NPSR1PIK3CD
SCHEMBL77839 0.84 RAB9A (0.61) SMN1; SMN2PIK3CDPIK3CAPIK3CBPIK3CG
Hydrochloric Acid SCHEMBL27769376 0.82 RAB9A (0.59) SMN1; SMN2PIK3CDPIK3CAPIK3CBPIK3CG
Hydrochloric Acid SCHEMBL10831817 0.82 RAB9A (0.59) SMN1; SMN2PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL780242 0.81 SMN1; SMN2 (0.61) LOXL2IDO1SMN1; SMN2NPSR1ALDH1A1
Nitrogen SCHEMBL29238121 0.81 RAB9A (0.58) SMN1; SMN2PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL2190447 0.79 ALDH1A1 (0.61) SMN1; SMN2PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL7409329 0.78 SMN1; SMN2 (0.58) LOXL2IDO1SMN1; SMN2NPSR1ALDH1A1
Hydrochloric Acid SCHEMBL11236118 0.78 ALDH1A1 (0.59) SMN1; SMN2PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL72699 0.76 GAA (0.72) SMN1; SMN2NPSR1PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3758697-B1 NOVEL ANTIMYCOBACTERIAL HETEROCYCLIC AMIDES CRESTONE INC (US) 2024-10-16 EP claimed
CN-112423746-B Novel antimycobacterial heterocyclic amides 克莱斯通公司 2024-06-28 CN claimed
CN-117756742-B Benzothiazole compound or salt thereof, preparation method and application thereof 徐州医科大学 2025-03-04 CN disclosed
CN-113727972-B Novel hydrazone derivatives having terminal amine groups substituted with aryl or heteroaryl groups and use thereof 韩国科学技术研究院 2024-12-27 CN disclosed
CN-118772080-A Antimycobacterial heterocyclic amides 克莱斯通公司 2024-10-15 CN disclosed
CN-112423746-B Novel antimycobacterial heterocyclic amides 克莱斯通公司 2024-06-28 CN disclosed
EP-4308554-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA The Board of Trustees of the University of Illinois (US) 2024-01-24 EP disclosed
WO-2022256609-A1 MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAY ALTOS LABS, INC. (US) 2022-12-08 WO disclosed
WO-2022212902-A1 MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAY ALTOS LABS, INC. (US) 2022-10-06 WO disclosed
WO-2022197658-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2022-09-22 WO disclosed